Neurogene Inc. NGNE 深 滬
等待開盤 05-14 09:30:00 美东时间
31.85
+0.310
+0.98%
華盛通- 最 高32.885
- 今 開31.54
- 成交量 8.51万股
- 最 低 29.77
- 昨 收 31.54
- 總市值 4.97亿
- 52周最高 37.2659
- 市盈率 靜 --
- 換手率 0.54%
- 52周最低 14.65
- 委 比 -94.26%
- 總股本 1561.58万
- 歷史最高 362.60
- 量 比 0.54
- 振 幅 9.88%
- 歷史最低 6.875
- 每 手 1
- 風險率 4.29%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Neurogene Q1 EPS $(1.39) Misses $(1.36) Estimate
Neurogene (NASDAQ:NGNE) reported quarterly losses of $(1.39) per share which missed the analyst consensus estimate of $(1.36) by 2.21 percent. This is a 28.7 percent decrease over losses of $(1.08) per share from the
05-13 05:06
美股大行评级 | 目标价31美元，潜在涨幅64%！多家大行首予PayPay"买入"评级； 大摩上调希捷科技目标价从468美元升至582美元
今日重点评级关注：Canaccord Genuity：维持Taysha Gene Therapies"买入"评级，目标价从14美元升至17美元；Guggenheim：维持天演药业"买入"评级，目标价从9美元升至10美元
04-07 11:53
Canaccord Genuity Maintains Buy on Neurogene, Lowers Price Target to $180
Canaccord Genuity analyst Whitney Ijem maintains Neurogene (NASDAQ:NGNE) with a Buy and lowers the price target from $200 to $180.
04-06 23:13
Neurogene shares are trading higher. The company reported Q4 financial results.
Neurogene shares are trading higher. The company reported Q4 financial results.
03-26 00:09
Neurogene Q4 EPS $(1.13), Inline
Neurogene (NASDAQ:NGNE) reported quarterly losses of $(1.13) per share which met the analyst consensus estimate. This is a 13 percent decrease over losses of $(1.00) per share from the same period last year.
03-24 19:39
美股大行评级 | 下调居多！多邻国、Elastic、Flutter、欧特克、Zscaler等遭多家机构下调目标价
今日重点评级关注：巴克莱：维持C4 Therapeutics"超配"评级，目标价从5美元升至7美元；富国银行：维持Agilon Health"超配"评级，目标价从1美元升至1.5美元
03-02 14:08
Autodesk, Arlo Technologies, Beyond Meat, Netflix And Other Big Stocks Moving Higher On Friday
Autodesk Inc (ADSK) rose sharply after beating Q4 earnings & issuing strong guidance. Other gainers include AAOI, NGNE, ARLO, PRAA, BYND, BWIN, PSKY, & DELL.
02-28 01:52
Neurogene shares are trading higher after the company announced that the FDA granted Breakthrough Therapy designation to NGN-401.
Neurogene shares are trading higher after the company announced that the FDA gr...
02-27 05:56
美股大行评级 | 斯伦贝谢、SouthState Bank、西屋制动、特里科银行获多家大行上调目标价；苹果、meta、微软等绩前遭下调目标价
今日重点评级关注：Oppenheimer：维持Pelthos Therapeutics"跑赢大市"评级，目标价从57美元升至60美元；Small Cap Consumer Research：维持Lands' End"买入"评级，目标价从20美元升至45美元
01-27 10:02
LifeSci Capital Initiates Coverage On Neurogene with Outperform Rating, Announces Price Target of $50
LifeSci Capital analyst Patrick Dolezal initiates coverage on Neurogene (NASDAQ:NGNE) with a Outperform rating and announces Price Target of $50.
01-26 21:45
